National HealthCare (NHC)
(Delayed Data from AMEX)
$91.28 USD
+0.51 (0.56%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $91.27 -0.01 (-0.01%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for National HealthCare Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,142 | 1,086 | 1,074 | 1,028 | 996 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 1,142 | 1,086 | 1,074 | 1,028 | 996 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,084 | 1,053 | 1,023 | 979 | 944 |
Income After Depreciation & Amortization | 57 | 32 | 52 | 50 | 52 |
Non-Operating Income | 32 | -5 | 99 | 4 | 39 |
Interest Expense | 0 | 1 | 1 | 1 | 3 |
Pretax Income | 89 | 27 | 150 | 52 | 88 |
Income Taxes | 23 | 7 | 11 | 10 | 20 |
Minority Interest | -2 | -2 | 1 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 65 | 20 | 139 | 42 | 68 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 67 | 22 | 139 | 42 | 68 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 99 | 73 | 92 | 92 | 95 |
Depreciation & Amortization (Cash Flow) | 42 | 40 | 41 | 42 | 42 |
Income After Depreciation & Amortization | 57 | 32 | 52 | 50 | 52 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 15.38 | 15.45 | 15.42 | 15.37 | 15.36 |
Diluted EPS Before Non-Recurring Items | 3.39 | 2.29 | 3.93 | 3.68 | 3.76 |
Diluted Net EPS (GAAP) | 4.34 | 1.45 | 8.99 | 2.72 | 4.44 |
Fiscal Year end for National HealthCare Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 300.91 | 288.49 | 282.58 | 269.56 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 300.91 | 288.49 | 282.58 | 269.56 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 280.74 | 275.39 | 268.51 | 259.46 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 20.17 | 13.10 | 14.07 | 10.10 |
Non-Operating Income | NA | 16.55 | 1.00 | 8.35 | 5.71 |
Interest Expense | NA | 0.06 | 0.08 | 0.09 | 0.10 |
Pretax Income | NA | 36.67 | 14.03 | 22.32 | 15.72 |
Income Taxes | NA | 8.70 | 3.91 | 6.41 | 4.44 |
Minority Interest | NA | -0.44 | -0.27 | -0.36 | -0.44 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 27.96 | 10.12 | 15.92 | 11.29 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 28.41 | 10.39 | 16.28 | 11.72 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 15.49 | 15.33 | 15.32 | 15.36 |
Diluted EPS Before Non-Recurring Items | NA | 0.98 | 0.83 | 0.89 | 0.79 |
Diluted Net EPS (GAAP) | NA | 1.84 | 0.68 | 1.06 | 0.76 |